Patents by Inventor Degang Song

Degang Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12077585
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: September 3, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn La Porte
  • Patent number: 12071466
    Abstract: The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a human Kallikrein-2 (hK2), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: August 27, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Raymond Brittingham, Rajkumar Ganesan, Sherry La Porte, John T. Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Sanjaya Singh, Degang Song, Sathyadevi Venkataramani, Fang Yi, Yonghong Zhao
  • Publication number: 20240124583
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn LaPorte
  • Publication number: 20230174651
    Abstract: An antibody that binds a CD8? hinge region, wherein the antibody is capable of binding to a functional exogenous receptor, and wherein the functional exogenous receptor comprises an extracellular domain, the CD8? hinge region, a transmembrane domain, and an intracellular signaling domain.
    Type: Application
    Filed: June 20, 2022
    Publication date: June 8, 2023
    Inventors: Jun CHEN, Martin Jack BORROK, III, Rajkumar GANESAN, Degang SONG, Shixue SHEN, Bonnie WU
  • Publication number: 20220064254
    Abstract: The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a human Kallikrein-2 (hK2), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
    Type: Application
    Filed: July 23, 2020
    Publication date: March 3, 2022
    Inventors: Raymond BRITTINGHAM, Rajkumar GANESAN, Sherry LA PORTE, John T. LEE, Jinquan LUO, Theresa MCDEVITT, Fei SHEN, Sanjaya SINGH, Degang SONG, Sathyadevi VENKATARAMANI, Fang YI, Yonghong ZHAO
  • Publication number: 20210040210
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Application
    Filed: July 23, 2020
    Publication date: February 11, 2021
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn La Porte